TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
TCL Archive NCAB Committee, NCI Split On Starting New Organ Systems Autodigestive Group February 15, 1985
TCL Archive New NCI Director Plans Greater Support For Translational Research, Collaboration. March 1, 2002